ECM
ALBO
Endurant Capital Management’s Albireo Pharma, Inc. Common Stock ALBO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-217,209
| Closed | -$4.69M | – | 67 |
|
|
2022
Q4 | $4.69M | Buy |
217,209
+44,588
| +26% | +$964K | 1.91% | 14 |
|
|
2022
Q3 | $3.34M | Buy |
172,621
+134,786
| +356% | +$2.61M | 1.09% | 26 |
|
|
2022
Q2 | $751K | Sell |
37,835
-82,999
| -69% | -$1.65M | 0.26% | 39 |
|
|
2022
Q1 | $3.6M | Buy |
120,834
+55,196
| +84% | +$1.65M | 0.95% | 28 |
|
|
2021
Q4 | $1.53M | Sell |
65,638
-51,690
| -44% | -$1.2M | 0.37% | 46 |
|
|
2021
Q3 | $3.66M | Buy |
117,328
+13,816
| +13% | +$431K | 0.83% | 28 |
|
|
2021
Q2 | $3.64M | Buy |
103,512
+337
| +0.3% | +$11.9K | 1% | 38 |
|
|
2021
Q1 | $3.64M | Buy |
103,175
+60,883
| +144% | +$2.15M | 0.95% | 37 |
|
|
2020
Q4 | $1.59M | Sell |
42,292
-9,839
| -19% | -$369K | 0.57% | 44 |
|
|
2020
Q3 | $1.74M | Buy |
+52,131
| New | +$1.74M | 0.51% | 46 |
|